119 related articles for article (PubMed ID: 28148946)
21. CRISPR/Cas9 for genome editing: progress, implications and challenges.
Zhang F; Wen Y; Guo X
Hum Mol Genet; 2014 Sep; 23(R1):R40-6. PubMed ID: 24651067
[TBL] [Abstract][Full Text] [Related]
22. CRISPR adaptation in Escherichia coli subtypeI-E system.
Kiro R; Goren MG; Yosef I; Qimron U
Biochem Soc Trans; 2013 Dec; 41(6):1412-5. PubMed ID: 24256229
[TBL] [Abstract][Full Text] [Related]
23. [The affair "Crispr-Cas9" or genetically enhanced humanity].
Nau JY
Rev Med Suisse; 2014 Jun; 10(436):1428-9. PubMed ID: 25055481
[No Abstract] [Full Text] [Related]
24. Retroviral Vectors for Cancer Gene Therapy.
Schambach A; Morgan M
Recent Results Cancer Res; 2016; 209():17-35. PubMed ID: 28101685
[TBL] [Abstract][Full Text] [Related]
25. Clustered Regularly Interspaced Short Palindromic Repeats Are emm Type-Specific in Highly Prevalent Group A Streptococci.
Zheng PX; Chan YC; Chiou CS; Chiang-Ni C; Wang SY; Tsai PJ; Chuang WJ; Lin YS; Liu CC; Wu JJ
PLoS One; 2015; 10(12):e0145223. PubMed ID: 26710228
[TBL] [Abstract][Full Text] [Related]
26. Rscreenorm: normalization of CRISPR and siRNA screen data for more reproducible hit selection.
Bachas C; Hodzic J; van der Mijn JC; Stoepker C; Verheul HMW; Wolthuis RMF; Felley-Bosco E; van Wieringen WN; van Beusechem VW; Brakenhoff RH; de Menezes RX
BMC Bioinformatics; 2018 Aug; 19(1):301. PubMed ID: 30126372
[TBL] [Abstract][Full Text] [Related]
27. Ji Luo Elucidates the CRISPR Gene Editing Technology, and How It May Affect Cancer Therapy in the Future.
Luo J
Oncology (Williston Park); 2016 Oct; 30(10):879. PubMed ID: 27753053
[No Abstract] [Full Text] [Related]
28. Genetic correction using engineered nucleases for gene therapy applications.
Li HL; Nakano T; Hotta A
Dev Growth Differ; 2014 Jan; 56(1):63-77. PubMed ID: 24329887
[TBL] [Abstract][Full Text] [Related]
29. Adaptation in CRISPR-Cas Systems.
Sternberg SH; Richter H; Charpentier E; Qimron U
Mol Cell; 2016 Mar; 61(6):797-808. PubMed ID: 26949040
[TBL] [Abstract][Full Text] [Related]
30. Advances in CRISPR-Cas9 genome engineering: lessons learned from RNA interference.
Barrangou R; Birmingham A; Wiemann S; Beijersbergen RL; Hornung V; Smith Av
Nucleic Acids Res; 2015 Apr; 43(7):3407-19. PubMed ID: 25800748
[TBL] [Abstract][Full Text] [Related]
31. Current and future delivery systems for engineered nucleases: ZFN, TALEN and RGEN.
Ul Ain Q; Chung JY; Kim YH
J Control Release; 2015 May; 205():120-7. PubMed ID: 25553825
[TBL] [Abstract][Full Text] [Related]
32. Multistage regulator based on tandem promoters and CRISPR/Cas.
Jia H; Liang T; Wang Z; He Z; Liu Y; Yang L; Zeng Y; Liu S; Tang L; Wang J; Chen Y; Xie Z
ACS Synth Biol; 2014 Dec; 3(12):1007-10. PubMed ID: 25524111
[TBL] [Abstract][Full Text] [Related]
33. Editing and investigating genomes with TALE and CRISPR/Cas systems: applications of artificial TALE and CRISPR-Cas systems.
Giovannangeli C; Concordet JP
Methods; 2014 Sep; 69(2):119-20. PubMed ID: 25248487
[No Abstract] [Full Text] [Related]
34. CRISPR/Cas9: molecular tool for gene therapy to target genome and epigenome in the treatment of lung cancer.
Sachdeva M; Sachdeva N; Pal M; Gupta N; Khan IA; Majumdar M; Tiwari A
Cancer Gene Ther; 2015 Nov; 22(11):509-17. PubMed ID: 26494554
[TBL] [Abstract][Full Text] [Related]
35. A new world order: tailored gene targeting and regulation using CRISPR.
Weinberg MS; Morris KV
Mol Ther; 2014 May; 22(5):893. PubMed ID: 24787973
[No Abstract] [Full Text] [Related]
36. [Not Available].
Nau JY
Rev Med Suisse; 2016 Mar; 12(512):666-7. PubMed ID: 27172698
[No Abstract] [Full Text] [Related]
37. Computational Detection of CRISPR/crRNA Targets.
Biswas A; Fineran PC; Brown CM
Methods Mol Biol; 2015; 1311():77-89. PubMed ID: 25981467
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of HIV-1 Viral Infection by an Engineered CRISPR Csy4 RNA Endoribonuclease.
Guo R; Wang H; Cui J; Wang G; Li W; Hu JF
PLoS One; 2015; 10(10):e0141335. PubMed ID: 26495836
[TBL] [Abstract][Full Text] [Related]
39. [Clustered regularly interspaced short palindromic repeats (CRISPR) site in Bacillus anthracis].
Gao Z; Wang D; Feng E; Wang B; Hui Y; Han S; Jiao L; Liu X; Wang H
Wei Sheng Wu Xue Bao; 2014 Nov; 54(11):1362-8. PubMed ID: 25752143
[TBL] [Abstract][Full Text] [Related]
40. Gene drive overdrive.
Nat Biotechnol; 2015 Oct; 33(10):1019-21. PubMed ID: 26448078
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
